Wordt geladen...
Development of Helicobacter pylori treatment: How do we manage antimicrobial resistance?
Helicobacter pylori (H. pylori) antimicrobial resistance is an urgent, global issue. In 2017, the World Health Organization designated clarithromycin-resistant H. pylori as a high priority bacterium for antibiotic research and development. In addition to clarithromycin, resistance to metronidazole a...
Bewaard in:
| Gepubliceerd in: | World J Gastroenterol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Baishideng Publishing Group Inc
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6487377/ https://ncbi.nlm.nih.gov/pubmed/31086459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v25.i16.1907 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|